Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lazo

Showing results (701-710 of 2,226) with videos related to

Pageof 223
Sort By:
Blood|August 26, 2006
The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 geneAlejandro Lazo-Langner, Greg A Knoll, Philip S Wells, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 4, 2008
Intrahospital correlation of the international normalized ratioAlejandro Lazo-Langner, Rosario Villa-Márquez, Darinel Hernández-Hernández, et al.
Archives of Endocrinology and Metabolism|May 5, 2025
Awareness, treatment, and control of diabetes in South America: A systematic review and meta-analysisJorge Emerson Chachaima-Mar, Alexandra Isabel Ramirez Moreno, Kenjiro Chau Ruiz, et al.
Cancer Research|May 15, 1995
Metallothionein null cells have increased sensitivity to anticancer drugsY Kondo, E S Woo, A E Michalska, et al.
Frontiers in Cellular Neuroscience|March 12, 2014
Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyLuis B Tovar-Y-Romo, Uri Nimrod Ramírez-Jarquín, Rafael Lazo-Gómez, et al.
Transfusion|February 3, 2017
Blood donation and testosterone replacement therapyBenjamin Chin-Yee, Alejandro Lazo-Langner, Terrie Butler-Foster, et al.
Oncology Research|January 1, 1992
In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64J P Jani, J S Mistry, G Morris, et al.
Cancer Research|January 1, 1991
Metabolic inactivation: a mechanism of human tumor resistance to bleomycinS M Sebti, J P Jani, J S Mistry, et al.
Annals of the ICRP|April 13, 2018
Implementation of the integrated approach in different types of exposure scenariosD Copplestone, G Hirth, M Johansen, et al.
BMC Research Notes|August 20, 2008
The complete chloroplast genome sequence of Brachypodium distachyon: sequence comparison and phylogenetic analysis of eight grass plastomesEsteban Bortiri, Devin Coleman-Derr, Gerard R Lazo, et al.
Pageof 223

Showing results (701-710 of 2,226) with videos related to

Sort By:
Pageof 223
Blood|August 26, 2006
The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 geneAlejandro Lazo-Langner, Greg A Knoll, Philip S Wells, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 4, 2008
Intrahospital correlation of the international normalized ratioAlejandro Lazo-Langner, Rosario Villa-Márquez, Darinel Hernández-Hernández, et al.
Archives of Endocrinology and Metabolism|May 5, 2025
Awareness, treatment, and control of diabetes in South America: A systematic review and meta-analysisJorge Emerson Chachaima-Mar, Alexandra Isabel Ramirez Moreno, Kenjiro Chau Ruiz, et al.
Cancer Research|May 15, 1995
Metallothionein null cells have increased sensitivity to anticancer drugsY Kondo, E S Woo, A E Michalska, et al.
Frontiers in Cellular Neuroscience|March 12, 2014
Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyLuis B Tovar-Y-Romo, Uri Nimrod Ramírez-Jarquín, Rafael Lazo-Gómez, et al.
Transfusion|February 3, 2017
Blood donation and testosterone replacement therapyBenjamin Chin-Yee, Alejandro Lazo-Langner, Terrie Butler-Foster, et al.
Oncology Research|January 1, 1992
In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64J P Jani, J S Mistry, G Morris, et al.
Cancer Research|January 1, 1991
Metabolic inactivation: a mechanism of human tumor resistance to bleomycinS M Sebti, J P Jani, J S Mistry, et al.
Annals of the ICRP|April 13, 2018
Implementation of the integrated approach in different types of exposure scenariosD Copplestone, G Hirth, M Johansen, et al.
BMC Research Notes|August 20, 2008
The complete chloroplast genome sequence of Brachypodium distachyon: sequence comparison and phylogenetic analysis of eight grass plastomesEsteban Bortiri, Devin Coleman-Derr, Gerard R Lazo, et al.
Pageof 223